2006
DOI: 10.1002/eji.200535759
|View full text |Cite
|
Sign up to set email alerts
|

The long‐term but not the short‐term antiviral effectof IFN‐α depends on Flt3 ligand and pDC

Abstract: The cooperation between IFN-a/b and FL, the ligand of Fms-like tyrosine kinase 3 (Flt3), plays an important role in the defense against herpes simplex virus type 1 (HSV-1) in neonates. Treatment of neonatal mice with recombinant IFN-a has a shortterm, FL-independent and a long-term, FL-dependent protective effect against HSV-1. In mice lacking FL, neonatal resistance against HSV-1 is very low and DC numbers in the spleen are reduced. The treatment of these mice with rIFN-a at day 6 resulted in an increased res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
20
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 10 publications
(22 citation statements)
references
References 37 publications
2
20
0
Order By: Relevance
“…An identical delay in viral clearance from the cornea was observed when DCs were persistently depleted by DT treatment at −2, +1, and +3 dpi, suggesting a specific role in viral clearance for the cornea resident DC population or those infiltrating the cornea during the first 24 hours after infection. Although plasmacytoid DCs (pDC) are a major source of type I interferon in HSV-1 infected mice (33,34), pDCs are not present in the normal cornea, and are not depleted by DT treatment of CD11c-DTR mice(35). Therefore, we proposed that the delay in HSV-1 clearance following DC depletion did not reflect direct viral clearance by DCs, but rather DC regulation of another cell type that is the proximal mediator of viral clearance from the cornea.…”
Section: Discussionmentioning
confidence: 99%
“…An identical delay in viral clearance from the cornea was observed when DCs were persistently depleted by DT treatment at −2, +1, and +3 dpi, suggesting a specific role in viral clearance for the cornea resident DC population or those infiltrating the cornea during the first 24 hours after infection. Although plasmacytoid DCs (pDC) are a major source of type I interferon in HSV-1 infected mice (33,34), pDCs are not present in the normal cornea, and are not depleted by DT treatment of CD11c-DTR mice(35). Therefore, we proposed that the delay in HSV-1 clearance following DC depletion did not reflect direct viral clearance by DCs, but rather DC regulation of another cell type that is the proximal mediator of viral clearance from the cornea.…”
Section: Discussionmentioning
confidence: 99%
“…Some of these same conditions have also been reported to enhance circulating M-CSF levels. For example, the serum of patients with Langerhans cell histiocytosis displays increased FL and M-CSF, 30 viral infections and IFN-␣, both shown to increase circulating FL, also increase M-CSF, [31][32][33][34] the serum of patients with systemic lupus erythematosus (SLE) has increased FL 35 , and animal models of SLE report elevated M-CSF levels. 36 Within these settings, the simultaneous elevation of FL and M-CSF, with M-CSF previously not suggested as capable of enhancing DC subsets, potentiates a cooperative role for these growth factors in DC development.…”
Section: Discussionmentioning
confidence: 99%
“…This defect is detected both at the protein and mRNA levels. Interestingly, long-term resistance to HSV-1 could be induced in neonatal mice following IFN-a treatment at birth, highlighting the decisive role of IFN-a and pDC for viral resistance in early life [19]. The fact that TLR7-dependent type I IFN synthesis is impaired in cord blood pDC suggests that cord blood pDC responses to singlestranded RNA viruses would be also compromised.…”
Section: Discussionmentioning
confidence: 99%